Table 4.
First author | Year of publication | Study area | Study Design | Study setting | Study population | Mean age (in years) | Male (%) | Sample size | Etiologies |
---|---|---|---|---|---|---|---|---|---|
Halle [35] | 2014 | Urban | Cross-sectional | Hospital-based | Patients on maintenance hemodialysis | 49.4 | 66.4 | 113 | Hypertension (25.6%), Chronic glomerulonephritis (20.6%), diabetes mellitus (17.4%) |
Kaze [36] | 2014 | Urban | Cross-sectional | Hospital-based | Patients on maintenance hemodialysis | 52.7 | 64.0 | 45 | Hypertension (29%), chronic glomerulonephritis (24%), Diabetes mellitus (24%) |
Halle [37] | 2015 | Urban | Retrospective cohort | Hospital-based | Patients with ESRD | 47.4 | 66.0 | 863 | Hypertension (30.9%), glomerulonephritis (15.8%), diabetes mellitus (15.9%), HIV (6.6%), unknown (14.7%) |
Kaze [38] | 2015 | Urban | Retrospective cohort | Hospital-based | Patients admitted in the nephrology unit | 44.8 | 60.0 | 225 | Chronic glomerulonephritis (25.9%), hypertension (22.3%), diabetes mellitus (20.1%) |
Halle [39] | 2016 | Urban | Prospective cohort | Hospital-based | Patients on maintenance hemodialysis | 46.3 | 66.0 | 661 | Hypertension (28.3%), chronic glomerulonephritis (17.5%), diabetes mellitus (13.9%), hypertension and diabetes (7.3%), HIV (6.7%), unknown (16.9%) |
Halle [40] | 2016 | Urban | Cross-sectional | Hospital-based | Maintenance hemodialysis | 51 | 66.0 | 97 | Hypertension (25.8%) Chronic glomerulonephritis (20.6%) Diabetes mellitus (17,5%) |
Luma [41] | 2017 | Semi-urban | Cross-sectional | Hospital-based | Hemodialysis patients | 48 | 65.4 | 104 | Hypertension (40.4%), chronic glomerulonephritis (19.2%), HIVAN (11.5%), Diabetes mellitus (7.7%), obstructive nephropathy (2.9%), unknown (13.5%) |
Moor [42] | 2017 | Urban | Cross-sectional | Hospital-based | Patients on maintenance hemodialysis | 55 | 75.0 | 44 | Hypertension (59.1%), Diabetes mellitus (11.4%) |
NR Not Reported, ESRD End stage renal disease, HIVAN HIV associated nephropathy